Rarely has the fate of the world depended on an international competition like the one for a Covid-19 vaccine. It's a race against time, it's a race to save lives, it's a race for glory. The first vaccines are rolling out and more are in development.
Who gets to take the shots first? When will there be enough doses for the planet's 7.8 billion people? And how quickly can vaccines help bring the pandemic to an end?
I had to change Covid-19 vaccines midstream. Two months, five doctors and multiple Benadryls later, it was very clear the system isn’t set up to help non-cookie-cutter patients like me.
The FDA analyzed the vaccines' ability to induce neutralizing antibody responses in kids that were comparable to young adults, a concept known as immunobridging. Both met the agency's success criteria.
State Sen. Richard Pan’s proposal would go further than Gov. Gavin Newsom’s requirement
Without more precise data, “you don’t know what’s happening and you don’t have the ability to say how at risk is the health care workforce,” said Celine Gounder.
Europe is pitching a broad health alliance, while ignoring Africa’s call to waive vaccine patents.
The FDA said it would convene its independent panel of vaccine experts Feb. 15 to consider the data.
The study did not explain why protection against reinfection and hospitalization grew among those individuals with a prior infection during Delta.
After deadlock lasting 18 months, an agreement could be on the horizon.
The president’s team is putting the world vaccination effort at the center of its Covid-19 strategy. But it lacks the money to pay for it.
The grand pivot to Europe’s southern neighbor has not worked out as planned.